The National Cancer Institute (NCI) is offering the Innovative Research in Cancer Nanotechnology (IRCN) grant, a key initiative under the NCI Alliance for Nanotechnology in Cancer. This grant encourages applications for developing innovative research projects aimed at advancing cancer nanotechnology. Its core purpose is to enable multidisciplinary research and foster transformative discoveries in cancer biology and oncology through the strategic application of nanotechnology. Proposed projects should focus on overcoming significant barriers in these fields by utilizing nanotechnology, particularly emphasizing the fundamental understanding of how nanomaterials and nanodevices interact with biological systems. The scope includes research on delivering nanoparticles and nanodevices to specific cancer targets in living organisms, as well as characterizing in vitro detection and diagnostic tools.
Opportunity ID: 292850
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-17-240 |
Funding Opportunity Title: | Innovative Research in Cancer Nanotechnology (IRCN) (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 30, 2017 |
Last Updated Date: | – |
Original Closing Date for Applications: | May 21, 2020 |
Current Closing Date for Applications: | May 21, 2020 |
Archive Date: | Jun 26, 2020 |
Estimated Total Program Funding: | – |
Award Ceiling: | $450,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) State governments City or township governments Native American tribal governments (Federally recognized) For profit organizations other than small businesses Public and State controlled institutions of higher education Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Special district governments County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) encourages applications for the development of innovative research projects in cancer nanotechnology. This initiative, to be known as Innovative Research in Cancer Nanotechnology (IRCN), is a component of a broader program that is the NCI Alliance for Nanotechnology in Cancer. IRCN awards are designed to enable multidisciplinary research and transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. This scope includes research concerning the delivery of nanoparticles and/or nanodevices to desired and intended cancer targets in vivo and/or characterization of in vitro detection and diagnostic devices. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-17-240.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-D | Use for due dates on or before January 24, 2018 | PKG00231727 | Oct 21, 2017 | Jan 24, 2018 | View | |
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00235940 | Nov 08, 2017 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259035 | Oct 21, 2017 | May 21, 2020 | View |
Package 1
Mandatory forms
292850 RR_SF424_2_0-2.0.pdf
292850 PHS398_CoverPageSupplement_3_0-3.0.pdf
292850 RR_OtherProjectInfo_1_3-1.3.pdf
292850 PerformanceSite_2_0-2.0.pdf
292850 RR_KeyPersonExpanded_2_0-2.0.pdf
292850 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
292850 RR_Budget_1_3-1.3.pdf
292850 RR_SubawardBudget30_1_3-1.3.pdf
292850 PHS398_ModularBudget_1_2-1.2.pdf
292850 PHS_Inclusion_Enrollment_Report-1.0.pdf
292850 PHS_AssignmentRequestForm-1.0.pdf
Package 2
Mandatory forms
292850 RR_SF424_2_0-2.0.pdf
292850 PHS398_CoverPageSupplement_4_0-4.0.pdf
292850 RR_OtherProjectInfo_1_4-1.4.pdf
292850 PerformanceSite_2_0-2.0.pdf
292850 RR_KeyPersonExpanded_2_0-2.0.pdf
292850 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
292850 RR_Budget_1_4-1.4.pdf
292850 RR_SubawardBudget30_1_4-1.4.pdf
292850 PHS398_ModularBudget_1_2-1.2.pdf
292850 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
292850 RR_SF424_2_0-2.0.pdf
292850 PHS398_CoverPageSupplement_5_0-5.0.pdf
292850 RR_OtherProjectInfo_1_4-1.4.pdf
292850 PerformanceSite_2_0-2.0.pdf
292850 RR_KeyPersonExpanded_2_0-2.0.pdf
292850 PHS398_ResearchPlan_4_0-4.0.pdf
292850 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
292850 RR_Budget_1_4-1.4.pdf
292850 RR_SubawardBudget30_1_4-1.4.pdf
292850 PHS398_ModularBudget_1_2-1.2.pdf
292850 PHS_AssignmentRequestForm_3_0-3.0.pdf